SCHEMBL697398

SCHEMBL697398

CCc1c(C)cccc1C(C)=O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRPF1 P55201 1/20 0.43
ALDH1A1 P00352 4/20 0.42
HPGD P15428 3/20 0.42
KDM4E B2RXH2 3/20 0.42
HSD17B10 Q99714 2/20 0.42
SMN1; SMN2 Q16637 4/20 0.40
TSHR P16473 2/20 0.39
MYC P01106 1/20 0.39
F2R P25116 1/20 0.39
ERCC5 P28715 1/20 0.38
FEN1 P39748 1/20 0.38
PPARG P37231 1/20 0.38
RAB9A P51151 3/20 0.37
POLB P06746 1/20 0.37
PKM P14618 1/20 0.37
KMT2A Q03164 2/20 0.37
LMNA P02545 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2C9 P11712 1/20 0.37
CXCR5 P32302 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13148436 0.85 CXCR5 (0.50) BRPF1ALDH1A1HPGDKDM4EHSD17B10
SCHEMBL1549077 0.84 ALDH1A1 (0.57) ALDH1A1HPGDKDM4EHSD17B10TSHR
SCHEMBL10499032 0.83 GABRA1 (0.48) ALDH1A1KDM4ESMN1; SMN2TSHRF2R
SCHEMBL16957858 0.83 ALDH1A1 (0.37) ALDH1A1HPGDKDM4EHSD17B10TSHR
SCHEMBL28638059 0.83 CXCR5 (0.47) BRPF1ALDH1A1HPGDKDM4EHSD17B10
SCHEMBL22620281 0.82 BRPF1 (0.42) BRPF1ALDH1A1HPGDKDM4EHSD17B10
SCHEMBL1660584 0.82 PARP1 (0.46) ALDH1A1HPGDKDM4EHSD17B10TSHR
SCHEMBL23965589 0.82 HPGD (0.38) ALDH1A1HPGDKDM4EHSD17B10TSHR
SCHEMBL2007368 0.81 HPGD (0.44) ALDH1A1HPGDKDM4EHSD17B10TSHR
Hydrochloric Acid SCHEMBL28802432 0.81 ALDH1A1 (0.53) ALDH1A1HPGDKDM4EHSD17B10TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024127297-A1 3-FLUORO-4-HYDROXYBENZMIDE-CONTAINING INHIBITORS AND/OR DEGRADERS AND USES THEREOF PFIZER INC. (US) 2024-06-20 WO disclosed
US-20210145832-A1 TANK-BINDING KINASE-1 PROTACs AND ASSOCIATED METHODS OF USE ARVINAS OPERATIONS, INC. 2021-05-20 US disclosed
WO-2019164891-A9 BCMA-BINDING ANTIBODIES AND USES THEREOF CELGENE CORPORATION (US) 2020-09-17 WO disclosed
WO-2019164891-A1 BCMA-BINDING ANTIBODIES AND USES THEREOF CELGENE CORPORATION (US) 2019-08-29 WO disclosed
US-20180125821-A1 TAU-PROTEIN TARGETING PROTACS AND ASSOCIATED METHODS OF USE ARVINAS OPERATIONS, INC. 2018-05-10 US disclosed
EP-2423199-A1 Substituted imidazoles and their use as pesticides Pfizer Limited (GB) 2012-02-29 EP disclosed
EP-1981853-B1 SUBSTITUTED IMIDAZOLES AND THEIR USE AS PESTICIDES PFIZER LTD (GB) 2011-04-13 EP disclosed
US-7825149-B2 Substituted imidazoles PFIZER LIMITED (GB) 2010-11-02 US disclosed
US-20090312326-A1 SUBSTITUTED IMIDAZOLES PFIZER LIMITED (GB) 2009-12-17 US disclosed
US-7592362-B2 Substituted imidazoles PFIZER LIMITED (GB) 2009-09-22 US disclosed
US-7547718-B2 Substituted imidazoles PFIZER LIMITED (GB) 2009-06-16 US disclosed
US-7544706-B2 Substituted imidazoles PFIZER LIMITED (GB) 2009-06-09 US disclosed
US-20080125473-A1 SUBSTITUTED IMIDAZOLES PFIZER LIMITED (GB) 2008-05-29 US disclosed
US-20080119536-A1 SUBSTITUTED IMIDAZOLES PFIZER LIMITED (GB) 2008-05-22 US disclosed
US-20070167506-A1 SUBSTITUTED IMIDAZOLES PFIZER INC. (US) 2007-07-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080125473-A1 SUBSTITUTED IMIDAZOLES ABL1, TYR, CYP3A4 BRPF1 1477/4885ALDH1A1 617/4885HPGD 2124/4885
US-20090312326-A1 SUBSTITUTED IMIDAZOLES ABL1, TYR, CYP3A4 BRPF1 1477/4885ALDH1A1 617/4885HPGD 2124/4885
US-20210145832-A1 TANK-BINDING KINASE-1 PROTACs AND ASSOCIATED METHODS OF USE TBK1, TNKS, TBKBP1 BRPF1 1906/4885ALDH1A1 4325/4885HPGD 4463/4885
US-20180125821-A1 TAU-PROTEIN TARGETING PROTACS AND ASSOCIATED METHODS OF USE CRBN, VHL, UBQLN2 BRPF1 2028/4885ALDH1A1 4249/4885HPGD 4448/4885
US-20070167506-A1 SUBSTITUTED IMIDAZOLES ABL1, TYR, CYP3A4 BRPF1 1477/4885ALDH1A1 617/4885HPGD 2124/4885
US-20080119536-A1 SUBSTITUTED IMIDAZOLES ABL1, TYR, CYP3A4 BRPF1 1477/4885ALDH1A1 617/4885HPGD 2124/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.